Patents Assigned to nanoPET Pharma GmbH
  • Diagnostic substances for optical imaging testing on the basis of nanoparticular formulations
    Patent number: 9821077
    Abstract: The present invention relates to the provision of nanoparticular formulations comprising a PEG-alkyl block copolymer and a near infrared fluorescent dye, the preparation of these nanoparticular formulations, pharmaceutical compositions comprising the nanoparticular formulations of the present invention, as well as their use as contrast medium.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: November 21, 2017
    Assignee: NANOPET PHARMA GMBH
    Inventor: Malte Bahner
  • Imaging diagnostics by combining contrast agents
    Patent number: 9682159
    Abstract: The present invention relates to the use of a combination of several contrast agents having different properties with respect to imaging representation.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: June 20, 2017
    Assignee: nanoPET Pharma GmbH
    Inventor: Ulrike Wiebelitz
  • Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
    Patent number: 8894968
    Abstract: The invention relates to pharmaceutical agents containing a particulate inorganic matrix having a diameter of from 0.1 nm to 100 ?m, preferably 1 nm to 10 ?m, particularly preferably 1 nm to 1 ?m, such as, for example, topaz, (Al2F2)[SiO4], and chiolite, Na[Al3F4], preferably wavellite, Al3(PO4)2(OH,F)2, calcium carbonate, CaCO3, maghemite, ?-Fe2O3, particularly preferably zeolites, gen. formula Mn[(AlO2)x(SiO2)y] (M=metal, e.g.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: November 25, 2014
    Assignee: nanoPET Pharma GmbH
    Inventor: Kristian Schilling
  • COMPOSITIONS EMITTING POSITRONS AND CONTAINING INORGANIC PARTICLES, AND USE THEREOF IN MEDICINE, ESPECIALLY FOR DIAGNOSTIC PROCESSES
    Publication number: 20100272637
    Abstract: The invention relates to pharmaceutical agents containing a particulate inorganic matrix having a diameter of from 0.1 nm to 100 ?m, preferably 1 nm to 10 ?m, particularly preferably 1 nm to 1 ?m, such as, for example, topaz, (Al2F2)[SiO4], and chiolite, Na[Al3F4], preferably wavellite, Al3(PO4)2(OH,F)2, calcium carbonate, CaCO3, maghemite, ?-Fe2O3, particularly preferably zeolites, gen. formula Mn[(AlO2)x(SiO2)y] (M=metal, e.g.
    Type: Application
    Filed: June 20, 2008
    Publication date: October 28, 2010
    Applicant: nanoPET Pharma GmbH
    Inventor: Kristian Schilling